The research highlights the potential benefits of paricalcitol, a second-generation vitamin D analog, in addressing renal secondary hyperparathyroidism (RHPT) and proteinuria—two critical ...

VDRAs can be used to manage secondary hyperparathyroidism at all stages of CKD and are likely to have additional benefits beyond the control of mineral and bone disorders, as has been shown in ...

Typically affecting older dogs, new research studies the benefits of paricalcitol, a drug used for the prevention and treatment of secondary hyperparathyroidism associated with chronic kidney failure.

The research highlights the potential benefits of paricalcitol, a second-generation vitamin D analog, in addressing renal secondary hyperparathyroidism (RHPT) and proteinuria—two critical ...